Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Y-Mabs Therapeutics (YMAB)
NASDAQ:YMAB
RESEARCH TOOLSreports
Holding YMAB?
Track your performance easily
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 18.46M | $ 22.80M | $ 19.93M | $ 23.36M | $ 20.45M |
| Gross Profit | $ 16.21M | $ 19.78M | $ 17.83M | $ 21.32M | $ 17.81M |
| EBIT | $ -6.65M | $ -9.15M | $ -6.86M | $ -3.20M | $ -7.75M |
| EBITDA | $ -6.53M | $ -9.00M | $ -6.70M | $ -3.04M | $ -7.58M |
| Net Income Common Stockholders | $ -7.00M | $ -9.25M | $ -6.63M | $ -988.00K | $ -7.75M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 68.12M | $ 77.81M | $ 75.75M | $ 78.64M | $ 86.57M |
| Total Assets | $ 120.92M | $ 144.03M | $ 123.31M | $ 127.87M | $ 128.88M |
| Total Debt | $ 1.07M | $ 1.27M | $ 1.18M | $ 1.42M | $ 1.62M |
| Net Debt | $ -67.05M | $ -76.53M | $ -74.57M | $ -77.22M | $ -84.95M |
| Total Liabilities | $ 28.49M | $ 48.70M | $ 24.13M | $ 26.88M | $ 28.73M |
| Stockholders Equity | $ 92.43M | $ 95.34M | $ 99.19M | $ 100.98M | $ 100.15M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -10.66M | $ 298.00K | $ -3.48M | $ -8.04M | $ -1.34M |
| Operating Cash Flow | $ -10.66M | $ 298.00K | $ -3.48M | $ -8.04M | $ -1.34M |
| Investing Cash Flow | - | - | - | - | - |
| Financing Cash Flow | $ 979.00K | $ 1.76M | $ 588.00K | $ 100.00K | - |